GPT-5 lowers the cost of cell-free protein synthesis
An autonomous laboratory system integrating OpenAI's GPT-5 with Ginkgo Bioworks' cloud automation platform achieved a 40% reduction in cell-free protein synthesis costs. The system operates via closed-loop experimentation, where the AI model iteratively designs, executes, and refines biological experiments without human intervention. This represents a concrete application of frontier LLMs to wet-lab automation and cost optimization in synthetic biology.
Related guides (3)
Related events (8)
OpenAI and Retro Biosciences Deploy GPT-4b micro for Protein Engineering in Longevity Research
OpenAI collaborated with Retro Biosciences to apply a specialized model called GPT-4b micro to protein engineering tasks relevant to stem cell therapy and longevity research. The work represents a concrete application of a fine-tuned or specialized variant of GPT-4 to life sciences, specifically improving protein design effectiveness. This is a notable example of frontier AI models being deployed in wet-lab-adjacent scientific research contexts.
Measuring AI's capability to accelerate biological research
OpenAI introduces a real-world evaluation framework designed to measure how AI systems can accelerate biological research in wet lab settings. The work uses GPT-5 to optimize a molecular cloning protocol as a concrete demonstration case. The framework explicitly addresses both the potential benefits and biosecurity risks of AI-assisted experimentation, positioning this as a dual-use capability assessment.
GPT-4o mini: advancing cost-efficient intelligence
OpenAI announced GPT-4o mini, a smaller and more cost-efficient version of GPT-4o, targeting applications that require lower latency and reduced inference costs. The model is positioned to outperform competing small models on key benchmarks while maintaining multimodal capabilities. It replaces GPT-3.5 Turbo as OpenAI's recommended entry-level model for cost-sensitive deployments.
OpenAI and Molecule.one demonstrate near-autonomous AI chemist using GPT-5.4 for medicinal chemistry
OpenAI and Molecule.one have demonstrated a near-autonomous AI chemist system built on GPT-5.4 that improved a challenging reaction in medicinal chemistry. The system represents a deployment of frontier AI in scientific research workflows, specifically drug synthesis optimization. This is notable as a concrete capability demonstration of agentic AI applied to chemistry R&D.
GPT-5.4 released with tool search, computer use, and frontier benchmark performance
OpenAI released GPT-5.4 in Thinking and Pro variants, featuring an expanded context window (up to 1.05M input tokens), native computer use, tool search capabilities, and adjustable reasoning levels. In independent testing by Artificial Analysis, GPT-5.4 Pro at xhigh reasoning achieved state-of-the-art on GDP-Val-AA, BrowseComp, Terminal-Bench-Hard, SWE-Bench-Pro, and MCP Atlas, while trailing Gemini 3.1 Pro Preview on MMMU-Pro and Humanity's Last Exam. Pricing is set at the top of the market ($30/$180 per million input/output tokens for Pro), and the release also powers Codex, OpenAI's competitor to Claude Code. The item is reported via The Batch (tier 2 commentary) and includes additional context on Andrew Ng's chub CLI tool for agent documentation sharing.
GPT-5.5 Bio Bug Bounty
OpenAI has launched a red-teaming bug bounty program specifically targeting biosafety risks in GPT-5.5, offering rewards up to $25,000. The program focuses on finding universal jailbreaks that could bypass biological safety guardrails. This represents a structured external adversarial evaluation of a frontier model's safety properties in a high-stakes domain.
Medical Research with GPT-5
OpenAI published a blog post describing how GPT-5 is being used for medical research applications. The post appears to be an announcement or case study highlighting GPT-5's capabilities in a healthcare/research context. Specific details about methods, benchmarks, or outcomes are not provided in the available text.
GPT-5 and the future of mathematical discovery
UCLA Professor Ernest Ryu collaborated with GPT-5 to solve an open problem in optimization theory, representing a concrete example of AI-assisted mathematical research. The announcement highlights GPT-5's capability in formal reasoning and scientific discovery beyond standard benchmarks. This is an OpenAI blog post showcasing a real-world research outcome involving a frontier model.